Skip to main content
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.185
-0.065 (-2.89%)
At close: Apr 28, 2026, 4:00 PM EDT
2.190
+0.005 (0.23%)
After-hours: Apr 28, 2026, 4:01 PM EDT

Allogene Therapeutics Employees

As of December 31, 2025, Allogene Therapeutics had 152 total employees, including 150 full-time and 2 part-time employees. The number of employees decreased by 77 or -33.62% compared to the previous year.

Employees
152
Change (1Y)
-77
Growth (1Y)
-33.62%
Revenue / Employee
n/a
Profits / Employee
-$1,255,829
Market Cap
751.59M

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025152-77-33.62%
Dec 31, 2024229-4-1.72%
Dec 31, 2023233-128-35.46%
Dec 31, 20223615116.45%
Dec 31, 20213104516.98%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Related Stocks

Company Name Employees
MannKind 592
Kura Oncology 260
ARS Pharmaceuticals 163
Solid Biosciences 121
Cullinan Therapeutics 109
Design Therapeutics 54
Crescent Biopharma 44
Arbutus Biopharma 19
Employee Rankings

ALLO News

More News